• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

225.42 +2.35 (+1.05%)
Official Closing Price Updated: 4:10 PM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,257,336
Open 224.80
Bid (Size) 224.00 (100)
Ask (Size) 226.00 (200)
Prev. Close 223.07
Today's Range 221.72 - 227.14
52wk Range 181.73 - 244.81
Shares Outstanding N/A
Dividend Yield 3.07%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Is AbbVie the Most Underrated Dividend Growth Stock in the S&P 500? ↗
June 08, 2026
For a solid yield and strong upside potential, this pharmaceutical stock is worth considering. 
Via The Motley Fool
Topics Intellectual Property Stocks
News headline image
The Best Stocks to Invest $500 in Right Now ↗
June 04, 2026
The market is underestimating these companies' long-term prospects. 
Via The Motley Fool

Performance

YTD
-1.7%
-1.7%
1 Month
+11.2%
+11.2%
3 Month
-0.9%
-0.9%
6 Month
+1.0%
+1.0%
1 Year
+19.2%
+19.2%

More News

Read More
News headline image
Dry eye syndrome drugs Market Size, Industry Report By 2035 ↗
June 04, 2026
Via Talk Markets
Topics Economy
News headline image
Buy 2 Vanguard Index Funds to Beat the S&P 500 in the Next Year, According to Wall Street ↗
June 03, 2026
Via The Motley Fool
Topics ETFs Intellectual Property Stocks
News headline image
Higher Yield or Broader Dividend Diversification? VYM vs. HDV ↗
June 02, 2026
Via The Motley Fool
Topics ETFs
News headline image
Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic ↗
June 02, 2026
Via The Motley Fool
News headline image
The S&P 500 Is Expensive, but These 3 Dividend Stocks Still Look Like Bargains ↗
June 02, 2026
Via The Motley Fool
Topics Stocks
News headline image
3 Dividend Stocks to Buy and Hold Forever ↗
June 02, 2026
Via The Motley Fool
News headline image
U.S. Health Care Depth or Global Industry Reach? VHT vs. IXJ ↗
June 01, 2026
Via The Motley Fool
Topics ETFs Intellectual Property
News headline image
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? ↗
June 01, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Allergy Treatment Market Size, Growth, Forecast By 2035 ↗
June 01, 2026
Via Talk Markets
Topics Economy
News headline image
Addiction Treatment Market Size, Demand, Growth By 2035 ↗
May 29, 2026
Via Talk Markets
Topics Economy
News headline image
VYM vs. SCHD: Which U.S. Dividend ETF Is a Better Buy? ↗
May 29, 2026
Via The Motley Fool
Topics ETFs
News headline image
2 ETFs That Have Held Up Best During Every Recent Market Pullback ↗
May 29, 2026
Via The Motley Fool
Topics ETFs Stocks
News headline image
Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders? ↗
May 28, 2026
Via MarketBeat
Topics Earnings
News headline image
5 High-Yield Stocks and ETFs to Buy and Hold for the Next Decade ↗
May 26, 2026
Via MarketBeat
Topics ETFs
News headline image
Prediction: These 2 Obesity Drug Stocks Could Double in 2026 ↗
May 26, 2026
Via The Motley Fool
News headline image
Chemical Peel Market Size, Industry Share By 2035 ↗
May 25, 2026
Via Talk Markets
Topics Economy
News headline image
What's the Better Dividend Stock Today: AbbVie or Pfizer? ↗
May 24, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Monster Dividend Stocks to Hold for the Next 10 Years ↗
May 24, 2026
Via The Motley Fool
Topics Energy Intellectual Property
News headline image
The Smartest Growth Stocks to Invest $10,000 in As Investors Rotate Out of Tech ↗
May 22, 2026
Via The Motley Fool
News headline image
Healthcare Stocks Are on Fire -- Don't Miss These Opportunities ↗
May 22, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Opinion: AbbVie Is the Best Dividend King to Buy in an Increasingly Uncertain Market ↗
May 22, 2026
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
2 Stocks That Are Much Cheaper Than They Look ↗
May 19, 2026
Via The Motley Fool
News headline image
2 High-Yield Healthcare Stocks to Buy Before They Raise Payouts ↗
May 19, 2026
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 225.42
When was AbbVie last traded?
The last trade of AbbVie was at 06/09/26 04:10 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap